248 results
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
10 May 24
TherapeuticsMD Announces First Quarter 2024 Financial Results
4:15pm
and cash equivalents totaled $4.3 million.
About TherapeuticsMD
TherapeuticsMD was previously a women’s healthcare company with a mission of creating
8-K
EX-99.1
TXMD
TherapeuticsMD Inc
29 Mar 24
TherapeuticsMD Announces Full Year 2023 Financial Results
4:29pm
totaled $4.3 million.
About TherapeuticsMD
TherapeuticsMD was previously a women’s healthcare company with a mission of creating and commercializing
8-K
EX-99.1
3trhms 26ls1qlvau
14 Nov 23
TherapeuticsMD Announces Third Quarter 2023 Financial Results
4:25pm
8-K
vo9bj0 phd
18 Aug 23
Entry into a Material Definitive Agreement
5:18pm
8-K
EX-99.1
8rfrzrzgys5wzw dmg
14 Aug 23
TherapeuticsMD Announces Second Quarter 2023 Financial Results
7:15am
8-K
EX-99.1
s9y56qwz1x8lfkfqk
15 May 23
TherapeuticsMD Announces First Quarter 2023 Financial Results
4:16pm
8-K
EX-10.2
j6dl71rv2v6w2
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
y9rijcmh hcyvco05
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
8-K
EX-99.1
noydplvb0p qe08
14 Nov 22
TherapeuticsMD Announces Third Quarter 2022 Financial Results
4:24pm